Chlamydia trachomatis is the most common cause of sexually transmitted venereal infection in the world.
It is composed of elementary bodies (the infectious form) and reticulate or inclusion bodies (the replicating
form). Chlamydia trachomatis has both a high prevalence and asymptomatic carriage rate, with frequent
serious complications in both women and neonates. Complications of Chlamydia infection in women
include cervicitis, urethritis, endometritis, pelvic inflammatory disease (PID) and increased incidence of
ectopic pregnancy and infertility.1 Vertical transmission of the disease during parturition from to neonate
can result in inclusion conjunctivitis or pneumonia. In men, complication of Chlamydia includes urethritis
and epididymitis. At least 40% of the nongonococcal urethritis cases are associated with Chlamydia
infection. Approximately 70% of women with endocervical infections and up to 50% of men with urethral
infections are asymptomatic. Traditionally, Chlamydia infection has been diagnosed by detection of
Chlamydia inclusions in tissue culture cells. Culture method is the most sensitive and specific laboratory
method, but it is labor intensive, expensive, long (18-72 hours) and not routinely available in most
situations.
The Chlamydia Rapid Test Cassette (Swab/Urine) is a rapid test to qualitatively detect the Chlamydia
antigen from female cervical swab, male urethral swab and male urine specimens